These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Designing an optimal intellectual property system for plants: a US Supreme Court debate. Janis MD; Kesan JP Nat Biotechnol; 2001 Oct; 19(10):981-3. PubMed ID: 11581668 [No Abstract] [Full Text] [Related]
6. Legal developments and practical implications of gene patenting on targeted drug discovery and development. Klein RD Clin Pharmacol Ther; 2010 Jun; 87(6):633-5. PubMed ID: 20485317 [TBL] [Abstract][Full Text] [Related]
7. What next for a COVID-19 intellectual property waiver? Zarocostas J Lancet; 2021 May; 397(10288):1871-1872. PubMed ID: 34022975 [No Abstract] [Full Text] [Related]
8. Waking up and smelling the coffee. Noonan KE Nat Biotechnol; 2010 Aug; 28(8):778-9; discussion 779. PubMed ID: 20697395 [No Abstract] [Full Text] [Related]
9. USA-Morocco deal may extend drug patents to 30 years. Ahmad K Lancet; 2003 Dec; 362(9399):1904. PubMed ID: 14672079 [No Abstract] [Full Text] [Related]
10. The effect of intellectual property on the biotechnology industry. Davis JH; Wales MM Adv Genet; 2003; 50():427-39; discussion 507-10. PubMed ID: 14714703 [No Abstract] [Full Text] [Related]
11. Gene patents in Australia: where do we stand? Simmons DP; Wickham ME Nat Biotechnol; 2012 Apr; 30(4):323-4. PubMed ID: 22491279 [No Abstract] [Full Text] [Related]
12. Enclosing the genome: what squabbles over genetic patents could teach us. Boyle J Adv Genet; 2003; 50():97-122; discussion 507-10. PubMed ID: 14714688 [No Abstract] [Full Text] [Related]
13. Steady the course: property rights in genetic material. Epstein RA Adv Genet; 2003; 50():153-94; discussion 507-10. PubMed ID: 14714690 [No Abstract] [Full Text] [Related]
14. Intellectual property: patents and transfer agreements preceding clinical trials and commercialization. Ross TP Retina; 2005 Dec; 25(8 Suppl):S91-S94. PubMed ID: 16374360 [No Abstract] [Full Text] [Related]
15. 23 and Me, We, and You: direct-to-consumer genetics, intellectual property, and informed consent. Allyse M Trends Biotechnol; 2013 Feb; 31(2):68-9. PubMed ID: 23237855 [No Abstract] [Full Text] [Related]
16. Intellectual property and products of nature. Sagoff M Am J Bioeth; 2002; 2(3):12-3. PubMed ID: 12230841 [No Abstract] [Full Text] [Related]
17. The common good. New Sci; 1999 Oct; 164(2210):3. PubMed ID: 11885620 [No Abstract] [Full Text] [Related]
18. Cereal gene bank accepts need for patents.. Dalton R Nature; 2000 Apr; 404(6778):534. PubMed ID: 10766206 [No Abstract] [Full Text] [Related]
19. International intellectual property strategies for therapeutic antibodies. Storz U MAbs; 2011; 3(6):596-606. PubMed ID: 22123063 [TBL] [Abstract][Full Text] [Related]
20. Intellectual property and access to ART: unwise choice of terminology. Stallman R PLoS Med; 2006 Nov; 3(11):e509; author reply e510. PubMed ID: 17132062 [No Abstract] [Full Text] [Related] [Next] [New Search]